journal article·2018-06-14Open access

A visible-light-controlled platform for prolonged drug release based on Ag-doped TiO2 nanotubes with a hydrophobic layer

Caihong Liang, Jiang Wen, Xiaoming Liao

Abstract

In this work, a visible-light-controlled drug release platform was constructed for localized and prolonged drug release based on two-layer titania nanotubes (TNTs) fabricated using by an in situ voltage up-anodization process. The visible-light photocatalytic activity is improved by loading Ag onto the TNTs by NaBH4 reduction. Then, the TNTs containing Ag nanoparticles were modified with dodecanethiol (NDM) to create a hydrophobic layer. To demonstrate the visible-light-controlled drug release, the Zn2+ release behavior of the samples was investigated. In the initial 12 h, TNTs without NDM displayed a faster release rate with 29.4% Zn2+ release, which was more than three times that of the TNTs with NDM (8.7% Zn2+ release). Upon visible-light illumination, drug release from the sample coated with NDM was shown to increase due to the photocatalytic decomposition of NDM. The amount of released Zn2+ for this sample increased up to 71.9% within 12 h, indicating visible-light-controlled drug release. This drug release system may exhibit promising application as a localized, prolonged drug delivery platform.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Photocatalysis Techniques · TiO2 Photocatalysis and Solar Cells · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. 10.1002/anie.20090261210.1002/anie.200902612 ↗
2. 10.1016/j.elecom.2005.07.01410.1016/j.elecom.2005.07.014 ↗
3. 10.1039/b509672c10.1039/b509672c ↗
4. 10.1038/4123310.1038/41233 ↗
5. 10.1039/b814334j10.1039/b814334j ↗
6. 10.1016/0142-9612(94)90092-210.1016/0142-9612(94)90092-2 ↗
7. 10.1002/(SICI)1097-4636(199602)30:2<145::AID-JBM3>3.0.CO;2-R10.1002/(SICI)1097-4636(199602)30:2<145::AID-JBM3>3.0.CO;2-R ↗
8. 10.1016/j.tsf.2007.12.00110.1016/j.tsf.2007.12.001 ↗
9. Smith · International Journal of Nanomedicine · 2007 · 2 · 493
10. 10.1149/1.273754410.1149/1.2737544 ↗
11. 10.1002/ange.20070414410.1002/ange.200704144 ↗
12. 10.1016/j.matlet.2007.09.08310.1016/j.matlet.2007.09.083 ↗
13. 10.1002/adma.20080118910.1002/adma.200801189 ↗
14. 10.1021/ja810130h10.1021/ja810130h ↗
15. 10.1016/j.jallcom.2015.06.01510.1016/j.jallcom.2015.06.015 ↗
16. 10.1039/C4TB01882F10.1039/C4TB01882F ↗
17. 10.1021/ja803947s10.1021/ja803947s ↗
18. 10.1021/ja070748i10.1021/ja070748i ↗
19. 10.1016/0005-2736(92)90183-M10.1016/0005-2736(92)90183-M ↗
20. 10.1021/nn500702g10.1021/nn500702g ↗
21. 10.1002/anie.20100603810.1002/anie.201006038 ↗
22. 10.1002/ange.20100061110.1002/ange.201000611 ↗
23. 10.1002/adma.20100207210.1002/adma.201002072 ↗
24. 10.1007/s00396005032910.1007/s003960050329 ↗
25. 10.1002/anie.20150871010.1002/anie.201508710 ↗
26. 10.1016/j.biomaterials.2013.01.07110.1016/j.biomaterials.2013.01.071 ↗
27. 10.1016/j.apsusc.2015.03.13310.1016/j.apsusc.2015.03.133 ↗
28. 10.1021/cm801796q10.1021/cm801796q ↗
29. 10.1016/j.vacuum.2007.04.03610.1016/j.vacuum.2007.04.036 ↗
30. 10.1016/j.matlet.2008.04.05210.1016/j.matlet.2008.04.052 ↗
31. 10.1021/es703134510.1021/es7031345 ↗
32. 10.1038/nmat125310.1038/nmat1253 ↗
33. 10.1021/acs.est.5b0375810.1021/acs.est.5b03758 ↗